4th Quarter - Termination

DLA PIPER LLP (US) for PLASMA PROTEIN THERAPEUTICS ASSOCIATION

Firm
Client
Income
$10,000
Expenses
—
Terminated
Oct 31, 2014

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to Orphan drug designation; 21st Century Cures Initiative; Issues related to drug discovery and development; International Plasma Protein Awareness Week.

LobbyistCovered position, as disclosed
NICOLE CARELLI —
VANESSA L. CRAMER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, issues related to plasma protein therapies.

LobbyistCovered position, as disclosed
NICOLE CARELLI —
TIFFANI WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4800 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.